FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992449754> ?p ?o ?g. }

• W1992449754 endingPage "340" @default.
• W1992449754 startingPage "331" @default.
• W1992449754 abstract "There is a lack of large studies appraising the effect of the human immunodeficiency virus (HIV) on the course of syphilis since the advent of highly active antiretroviral therapy (HAART). We aimed to appraise the effect of HIV on clinical and serologic features of syphilis at baseline and during follow-up in the post-HAART era. We designed a retrospective cohort study of consecutive syphilis cases, diagnosed between 2000 and 2007, in an academic venereal disease center. Data were collected using standardized medical forms. Patients were treated according to the European guidelines. Serologic failure was defined as either a 4-fold rise in Venereal Disease Research Laboratory (VDRL) titers 30-400 days posttreatment or a lack of 4-fold drop in VDRL titers at 270-400 days posttreatment. Among 279 syphilis cases with informative baseline clinical and serologic data, HIV infection was significantly associated with men having sex with men, French origin, multiple partners, lesser usage of condom, history of sexually transmitted disease, early syphilis, anal primary chancre, and cutaneous eruption. Median baseline titer from the Treponema pallidum hemagglutination assay (TPHA) was higher in HIV-infected patients (p = 0.02). Among 144 informative syphilis cases, there was a nonsignificant trend for a lower rate of serologic response among HIV-positive patients (91.8% vs. 98.3%, p = 0.14). Serologic failure was significantly associated with a history of previous syphilis (p < 0.05). The median delay to serologic response was similar in HIV-positive (117 d) and in HIV-negative (123 d) patients (p = 0.44). We conclude that for patients under HAART treatment, the effect of HIV on serologic response to syphilis treatment is likely minimal or absent. Abbreviations: CSF = cerebrospinal fluid, FTA-abs = fluorescent treponemal antibody absorption test, HAART = highly active antiretroviral therapy, HIV = human immunodeficiency virus, HR = hazard ratio, MSM = men having sex with men, RPR = rapid plasma reagin, STD = sexually transmitted disease, TPHA = Treponema pallidum hemagglutination assay, VDRL = Venereal Disease Research Laboratory." @default.
• W1992449754 created "2016-06-24" @default.
• W1992449754 creator A5002216203 @default.
• W1992449754 creator A5003697928 @default.
• W1992449754 creator A5004200189 @default.
• W1992449754 creator A5011205171 @default.
• W1992449754 creator A5019341717 @default.
• W1992449754 creator A5025331564 @default.
• W1992449754 creator A5025819708 @default.
• W1992449754 creator A5042447894 @default.
• W1992449754 creator A5056723192 @default.
• W1992449754 creator A5059373209 @default.
• W1992449754 date "2009-11-01" @default.
• W1992449754 modified "2023-10-18" @default.
• W1992449754 title "Clinical and Serologic Baseline and Follow-Up Features of Syphilis According to HIV Status in the Post-HAART Era" @default.
• W1992449754 cites W1969285065 @default.
• W1992449754 cites W1979514418 @default.
• W1992449754 cites W1980657363 @default.
• W1992449754 cites W1987761869 @default.
• W1992449754 cites W1995003342 @default.
• W1992449754 cites W1995393164 @default.
• W1992449754 cites W2007404003 @default.
• W1992449754 cites W2011659474 @default.
• W1992449754 cites W2020271938 @default.
• W1992449754 cites W2025129013 @default.
• W1992449754 cites W2026680729 @default.
• W1992449754 cites W2033698579 @default.
• W1992449754 cites W2034430231 @default.
• W1992449754 cites W2046397980 @default.
• W1992449754 cites W2048617640 @default.
• W1992449754 cites W2049752634 @default.
• W1992449754 cites W2054233015 @default.
• W1992449754 cites W2065432070 @default.
• W1992449754 cites W2074516129 @default.
• W1992449754 cites W2085335706 @default.
• W1992449754 cites W2092450746 @default.
• W1992449754 cites W2116969141 @default.
• W1992449754 cites W2138210371 @default.
• W1992449754 cites W2146112981 @default.
• W1992449754 cites W2146581862 @default.
• W1992449754 cites W2148246759 @default.
• W1992449754 cites W2156345163 @default.
• W1992449754 cites W2160124608 @default.
• W1992449754 cites W2165252369 @default.
• W1992449754 cites W2247937076 @default.
• W1992449754 cites W2325386765 @default.
• W1992449754 cites W4242673392 @default.
• W1992449754 cites W4252608177 @default.
• W1992449754 doi "https://doi.org/10.1097/md.0b013e3181c2af86" @default.
• W1992449754 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19910747" @default.
• W1992449754 hasPublicationYear "2009" @default.
• W1992449754 type Work @default.
• W1992449754 sameAs 1992449754 @default.
• W1992449754 citedByCount "44" @default.
• W1992449754 countsByYear W19924497542012 @default.
• W1992449754 countsByYear W19924497542013 @default.
• W1992449754 countsByYear W19924497542014 @default.
• W1992449754 countsByYear W19924497542015 @default.
• W1992449754 countsByYear W19924497542016 @default.
• W1992449754 countsByYear W19924497542017 @default.
• W1992449754 countsByYear W19924497542019 @default.
• W1992449754 countsByYear W19924497542020 @default.
• W1992449754 countsByYear W19924497542021 @default.
• W1992449754 crossrefType "journal-article" @default.
• W1992449754 hasAuthorship W1992449754A5002216203 @default.
• W1992449754 hasAuthorship W1992449754A5003697928 @default.
• W1992449754 hasAuthorship W1992449754A5004200189 @default.
• W1992449754 hasAuthorship W1992449754A5011205171 @default.
• W1992449754 hasAuthorship W1992449754A5019341717 @default.
• W1992449754 hasAuthorship W1992449754A5025331564 @default.
• W1992449754 hasAuthorship W1992449754A5025819708 @default.
• W1992449754 hasAuthorship W1992449754A5042447894 @default.
• W1992449754 hasAuthorship W1992449754A5056723192 @default.
• W1992449754 hasAuthorship W1992449754A5059373209 @default.
• W1992449754 hasBestOaLocation W19924497541 @default.
• W1992449754 hasConcept C126322002 @default.
• W1992449754 hasConcept C159654299 @default.
• W1992449754 hasConcept C167135981 @default.
• W1992449754 hasConcept C203014093 @default.
• W1992449754 hasConcept C2776908936 @default.
• W1992449754 hasConcept C2776939746 @default.
• W1992449754 hasConcept C2776983459 @default.
• W1992449754 hasConcept C2780187896 @default.
• W1992449754 hasConcept C2909760446 @default.
• W1992449754 hasConcept C3013748606 @default.
• W1992449754 hasConcept C45189115 @default.
• W1992449754 hasConcept C71924100 @default.
• W1992449754 hasConceptScore W1992449754C126322002 @default.
• W1992449754 hasConceptScore W1992449754C159654299 @default.
• W1992449754 hasConceptScore W1992449754C167135981 @default.
• W1992449754 hasConceptScore W1992449754C203014093 @default.
• W1992449754 hasConceptScore W1992449754C2776908936 @default.
• W1992449754 hasConceptScore W1992449754C2776939746 @default.
• W1992449754 hasConceptScore W1992449754C2776983459 @default.
• W1992449754 hasConceptScore W1992449754C2780187896 @default.
• W1992449754 hasConceptScore W1992449754C2909760446 @default.
• W1992449754 hasConceptScore W1992449754C3013748606 @default.
• W1992449754 hasConceptScore W1992449754C45189115 @default.

• next